Clinical pharmacy services in cancer patients with hypertension

Songul Tezcan,Feyza Nur Yılmaz

DOI: https://doi.org/10.1515/oncologie-2023-0514

2024-01-01

ONCOLOGIE

Abstract:Abstract Clinical pharmacy services aim to ensure the rational use of drugs and resolve disease/health conditions with a multidisciplinary approach. Pharmaceutical care plans need to be created to effectively provide clinical pharmacy services in the treatment of hypertension which is one of the common chronic diseases in cancer patients. In this mini-review, we examine which drugs can cause or worsen hypertension in patients receiving cancer treatment, potential drug-drug interactions between drugs used in cancer treatment and antihypertensive drugs, pharmacological and clinical studies for the treatment of hypertension in patients with hypertension before cancer diagnosis or newly diagnosed hypertension due to cancer treatment. Non-pharmacological treatment approaches are presented. We think that our study will be a resource that can be used to solve possible drug-related problems in the practice.

oncology

What problem does this paper attempt to address?

The paper attempts to address the issue of managing hypertension in cancer patients through clinical pharmacy services. Specifically, the authors focus on the following aspects:

1. **Drug-induced Hypertension**: Exploring which anticancer drugs may cause or exacerbate hypertension.
2. **Drug Interactions**: Analyzing potential drug-drug interactions (pDDIs) between anticancer drugs and antihypertensive medications to reduce adverse effects and improve therapeutic outcomes.
3. **Hypertension Treatment**: Introducing antihypertensive treatment methods in pharmacological and clinical research, including patients who had hypertension before cancer treatment and those who developed hypertension due to cancer treatment.
4. **Non-pharmacological Treatment**: Proposing non-pharmacological treatment measures such as lifestyle changes to reduce cardiovascular risk.

Through these contents, the authors hope to provide resources and support for addressing potential drug-related issues in clinical practice.